A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Clinical trial NCT06385678 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06385678
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced KRAS G12D Mutant Solid Tumors

Start date: 2024-07-05
Primary completion: 2025-12-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.